Document and Entity Information [Abstract] Document and entity information. Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Condensed Consolidated Balance Sheets [Abstract] ASSETS Assets [Abstract] Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Accounts Receivable, Net, Current Accounts receivable Liabilities and Stockholders' Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Other Liabilities Noncurrent Other liabilities Condensed Consolidated Statements of Comprehensive Income (Loss) [Abstract] Revenues Collaboration revenue Income (loss) from operations Operating Income (Loss) Interest Expense Interest expense Other Nonoperating Income (Expense) Other expense, net Net income (loss) Net Income (Loss) Attributable to Parent Net income (loss) attributed to common stockholders Net loss Net income (loss) attributed to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Earnings Per Share [Abstract] Net income (loss) per share attributed to common stockholders Calculation of weighted average shares of common stock Condensed Consolidated Statements of Cash Flows [Abstract] Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Net proceeds from issuance of common stock through equity plans Proceeds from Issuance of Common Stock Proceeds from issuance of common stock in equity offerings, net of issuance costs Issuance of common stock, net Cash and Cash Equivalents, Period Increase (Decrease) Net increase in cash and cash equivalents The Company [Abstract] The Company Nature Of Operations Summary of Significant Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies License and Supply Agreements [Abstract] License and supply agreements. Collaborative Arrangement Disclosure [Text Block] License and Supply Agreements Fair Value Measurements [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Balance Sheet Components [Abstract] Balance Sheet Components [Text Block] Balance Sheet Components Balance sheet components. Commitments and Contingencies [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Stockholders' Equity [Abstract] Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation Revenue Recognition, Policy [Policy Text Block] Revenue Recognition Compensation Related Costs, Policy [Policy Text Block] Stock-Based Compensation Earnings Per Share, Policy [Policy Text Block] Net income (loss) per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share Schedule of Restricted Cash and Cash Equivalents [Table Text Block] Summary of Cash, Cash Equivalents and Restricted Investment Fair Value, Assets Measured on Recurring Basis [Table Text Block] Financial Assets Measured and Recognized at Fair Value on Recurring Basis Schedule of Accrued Liabilities [Table Text Block] Accrued Liabilities Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Future Minimum Lease Payments for Operating Leases Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Schedule of Activity for Restricted Stock Units Under 2007 Plan Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Activity for Stock Options Under 2007 Plan Schedule of Stock-Based Compensation Expense Recognized [Table Text Block] Schedule of Stock-Based Compensation Expense Recognized Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Assumptions to Estimate Fair Value of Options Granted Under Stock Option Plan Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Schedule of Assumptions to Estimate Fair Value of Shares Purchased Under ESPP Award Type [Axis] Award Type [Domain] Stock Options [Member] Stock Options [Member] Warrant [Member] Warrant [Member] Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan (ESPP) [Member] Employee Stock Purchase Plan. Restricted Stock Units (RSUs) [Member] Restricted Stock Units R S U [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Options to Purchase Common Stock [Member] Options to Purchase Common Stock [Member] Options to purchase common stock. Restricted Stock Units with Time Based Vesting [Member] RSUs with Time-Based Vesting [Member] Restricted stock units with time based vesting. Restricted Stock Units with Performance Based Vesting [Member] RSUs with Performance-Based Vesting [Member] Restricted stock units with performance based vesting. Common Stock Issuable Pursuant to Employee Stock Purchase Plan [Member] Common Stock Issuable Pursuant to the ESPP [Member] Common stock issuable pursuant to the employee stock purchase plan. Warrants to Purchase Common Stock [Member] Warrants to Purchase Common Stock [Member] Warrants to purchase common stock. Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Computation of diluted net loss per share Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share License and Supply Agreements [Table] License and supply agreements. Collaborative Arrangements and Non-collaborative Arrangement Transactions [Axis] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Domain] Collaborative Arrangement, Product, Agreement [Member] Collaborative Arrangement Product Agreement [Member] Collaborative Arrangement, Product, Aggregated Disclosure [Member] Collaborative Arrangement Product Aggregated Disclosure [Member] Allergan [Member] Allergan [Member] Allergan. Nektar [Member] Nektar [Member] Nektar. License and Supply Agreements [Line Items] License and supply agreements. License and Supply Agreements (Textual) [Abstract] License and Supply Agreements (Textual) [Abstract] License and supply agreements. Prior Written Notice Period After Sale of Product for Termination of Collaboration Agreement Prior written notice period after sale of product for termination of collaboration agreement, in days Prior written notice period after sale of product for termination of collaboration agreement. Upfront Payment Upfront payment made by Allergan Upfront payment. Collaboration Revenue Recognized Collaboration revenue recognized Collaboration revenue recognized. Deferred Revenue to be Amortized as Collaboration Revenue Over Estimated Obligation Periods Deferred revenue to be amortized as collaboration revenue over estimated obligation period Deferred revenue to be amortized as collaboration revenue over estimated obligation periods. Milestone payment received as collaboration revenue from Allergan Revenue Recognition, Milestone Method, Revenue Recognized Additional Revenue Recognition Milestone Method Revenue to be Recognized Additional milestone payment to be received under Collaboration Agreement Additional revenue recognition milestone method revenue to be recognized. Additional Milestone Payment for First Commercial Sale Associated with Initial Indication Additional milestone payment for first commercial sale associated with initial indication Additional milestone payment for first commercial sale associated with initial indication. Additional Milestone Payment for Achievement of Certain Approved Product Labeling Additional milestone payment for achievement of certain FDA-approved product labeling in United States Additional milestone payment for achievement of certain approved product labeling. Additional Milestone Payment for Regulatory Approval of Initial Indication Additional milestone payment for regulatory approval of initial indication Additional milestone payment for regulatory approval of initial indication. Net Sales, General and Administrative Expenses Reimbursed or Reimbursable Under Collaboration Agreement Net of costs reimbursed or reimbursable under cost sharing provisions in collaboration agreement Net sales, general and administrative expenses reimbursed or reimbursable under collaboration agreement. Payments for Royalties Payments Fair Value, Option, Qualitative Disclosures Related to Election [Table] Schedule of Investment Income, Reported Amounts, by Category [Axis] Investment Income Categories [Domain] Cash [Member] Cash [Member] Certificates of Deposit [Member] Certificates of Deposit [Member] Money Market Funds [Member] Money Market Funds [Member] Cash and Cash Equivalents [Member] Cash and Cash Equivalents [Member] Restricted Investment [Member] Restricted Investment [Member] Restricted investment. Fair Value, Option, Qualitative Disclosures Related to Election [Line Items] Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Summary of Cash, Cash Equivalents and Restricted Investment Available-for-sale Securities, Amortized Cost Basis Amortized Cost Available-for-sale Securities, Fair Value Disclosure Estimated Fair Value Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Hierarchy [Axis] Fair Value Measurements Fair Value Hierarchy [Domain] Fair Value Inputs Level1 [Member] Level 1 [Member] Fair Value Inputs Level2 [Member] Level 2 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Financial assets measured and recognized at fair value on a recurring basis Assets, Fair Value Disclosure [Abstract] Assets, Fair Value Disclosure, Recurring Total Fair Value Measurements (Textual) [Abstract] Fair Value Measurements (Textual) [Abstract] Fair value measurements. Net Asset Value Per Share Fair Value Disclosure Net asset value per share Net asset value per share, fair value disclosure. Accrued Liabilities Accounts Payable and Accrued Liabilities, Current [Abstract] Employee Related Liabilities Current Payroll and related expenses Professional services Professional Services Other Other Accrued Liabilities, Current Operating Leases, Future Minimum Payments Due, Current 2012 (remaining three months) Operating Leases, Future Minimum Payments, Due in Two Years 2013 Operating Leases, Future Minimum Payments Due Total future minimum lease payments Commitments and Contingencies (Textual) [Abstract] Commitments and Contingencies (Textual) [Abstract] Commitments and Contingencies. Operating Leases, Rent Expense Rent expense Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Shares, outstanding, Ending Balance Number of Shares, outstanding, Beginning Balance Number of Shares, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Number of Shares, vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Number of Shares, forfeited Weighted Average Grant Date Fair Value, outstanding, Ending Balance Weighted Average Grant Date Fair Value, outstanding, Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, vested Activity For Stock Options Under 2007 Plan Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number of Shares, Balances, at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of Shares, Balances, at December 31, 2011 Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Number of Shares, Options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of Shares, Options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Number of Shares, Options forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Number of Shares, Options expired Weighted Average Exercise Price, Balances, at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price, Balances, at December 31, 2011 Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Employee Service Share Based Compensation Allocation Of Recognized Period Costs Report Line [Domain] Research and Development Expense [Member] Research and Development [Member] Sales General and Administrative Expense [Member] Sales, General and Administrative [Member] Sales general and administrative expense. Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Stock-Based Compensation Expense Recognized Share-based Compensation, Allocation and Classification in Financial Statements [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Assumptions to Estimate Fair Value of Options Granted Under Stock Option Plan Shares Purchased Under ESPP Risk-free interest rate, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Investment Type [Axis] Investment Type Categorization [Domain] Stockholders' Equity (Textual) [Abstract] Stockholders' Equity (Textual) [Abstract] Stockholders' Equity. Share Based Compensation Arrangement by Share Based Payment Award Award Annual Vesting Rate Annual vesting rate Share based compensation arrangement by share based payment award award annual vesting rate. Number of shares of common stock available for grant under 2007 Plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Number of shares of common stock to be purchased for issuance of warrants Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award Exercise price of warrants, per share Investment Warrants, Exercise Price Investments Warrants Expiration Date Warrants expiration date Investments warrants expiration date. Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Number of net issuance of shares Number of Shares of Common Stock Outstanding for Issuance of Warrants Number of shares of common stock outstanding for issuance of warrants Number of shares of common stock outstanding for issuance of warrants. Expected Dividend Yield Based on History and Expectation of Dividend Payouts Expected dividend yield based on history and expectation of dividend payouts Expected dividend yield based on history and expectation of dividend payouts. Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized Unrecognized compensation costs approximately related to non-vested stock option awards granted Share Based Compensation Nonvested Awards Compensation Cost not Yet Recognized Period for Recognition Weighted average remaining period recognized on straight-line basis, years Share based compensation nonvested awards compensation cost not yet recognized period. Available-for-sale Securities, Gross Unrealized Gain (Loss) Unrealized Gain (Loss) Fair Value, Inputs, Level 3 [Member] Level 3 [Member] Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Options granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Options exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Options forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Options expired Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Other Assets, Noncurrent Other assets Restricted Investments, Noncurrent Restricted investment Bank deposit account shown as restricted investment on condensed consolidated balance sheets Assets Total assets Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued liabilities Accrued liabilities Deferred Revenue, Current Current portion of deferred revenue Liabilities, Current Total current liabilities Deferred Revenue, Noncurrent Deferred revenue, less current portion Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Note 6) Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Common Stock, Value, Issued Common stock Additional Paid in Capital Additional paid-in capital Development Stage Enterprise, Deficit Accumulated During Development Stage Deficit accumulated during the development stage Stockholders' Equity Attributable to Parent Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development Selling, General and Administrative Expense Sales, general and administrative Operating Expenses Total operating expenses Investment Income, Interest Interest income Dividends, Preferred Stock Cumulative stock dividend attributed to preferred stockholders Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Accretion (Amortization) of Discounts and Premiums, Investments Accretion of investment discounts, net Amortization of Debt Discount (Premium) Accretion of debt payment premium Share-based Compensation Stock-based compensation expense Stock-based compensation Gain (Loss) on Sale of Property Plant Equipment Loss on disposal of equipment and other non-cash items Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Other Operating Assets Other assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities Accrued liabilities Increase (Decrease) in Deferred Revenue Deferred revenue Increase (Decrease) in Other Operating Liabilities Other liabilities Net Cash Provided by (Used in) Operating Activities Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Intangible Assets Purchase of intangible assets and in-process research and development Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Payments to Acquire Short-term Investments Purchase of short-term investments Proceeds from Sale of Short-term Investments Sales and maturities of short-term investments Payments to Acquire Restricted Investments Purchase of restricted investment Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Proceeds from Notes Payable Proceeds from issuance of convertible notes payable Proceeds from Issuance of Long-term Debt Proceeds from issuance of debt Proceeds from Stock Plans Repayments of Long-term Debt Repayment of debt Proceeds from Other Equity Proceeds from issuance of common stock resulting from drawdown of equity line of credit, net of issuance costs Proceeds from Issuance of Convertible Preferred Stock Proceeds from issuance of convertible preferred stock, net of issuance costs Net Cash Provided by (Used in) Financing Activities Net cash provided by (used in) financing activities Assets, Current [Abstract] Current assets: Liabilities, Current [Abstract] Current liabilities: Expiration Date of Lease Lease expiration date Expiration date of lease. Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Future Minimum Lease Payments for Operating Leases Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Activity For Restricted Stock Units Under 2007 Plan Reclassification, Policy [Policy Text Block] Reclassifications Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk and Other Risks and Uncertainties Summary of Significant Accounting Policies (Textual) [Abstract] Summary of Significant Accounting Policies (Textual) [Abstract] Summary of significant accounting policies. Accounts Receivable Accounts receivable Accounts receivable. Collaboration Revenue Collaboration revenue Collaboration revenue. Collaboration Revenue Unrecognized Collaboration revenue unrecognized. Collaboration revenue unrecognized Proceeds from Collaborators Cash Payment Received from Collaboration Agreement Deferred Revenue Deferred upfront cash payment Accrued Research and Development Liabilities Research and development Accrued research and development liabilities. Supplemental Cash Flow Information [Abstract] Supplemental disclosures of non-cash investing activities Capital Expenditures Incurred but Not yet Paid Purchase of property and equipment through accounts payable Maximum Maturity Period for Corporate Debt Securities Maximum maturity period for corporate debt securities. Maximum maturity for corporate debt securities Comprehensive Income (Loss), Net of Tax, Attributable to Parent Total comprehensive income (loss) Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurements Stockholders Equity (Additional Textual) [Abstract] Stockholders Equity (Additional Textual) [Abstract] Stockholders equity additional textual. New Accounting Pronouncements, Policy [Policy Text Block] New Accounting Standard Adopted Earnings Per Share, Basic Basic income (loss) per common share Basic Earnings Per Share, Diluted Diluted income (loss) per common share Diluted Weighted Average Shares Outstanding Used in Calculating Net Income Loss Per Share Attributed to Common Stockholders Weighted average shares outstanding used in calculating net income loss per share attributed to common stockholders. Weighted average shares outstanding used in calculating net income (loss) per share attributed to common stockholders Weighted Average Number of Shares Outstanding, Diluted Weighted average common shares used in computing diluted net income (loss) per common share Diluted Weighted Average Number of Shares Outstanding, Basic Weighted average common shares used in computing basic net income (loss) per common share Basic Weighted Average Number of Shares Outstanding, Basic [Abstract] Basic: Weighted Average Number Diluted Shares Outstanding Adjustment [Abstract] Diluted: Incremental Common Shares Attributable to Call Options and Warrants Add: Weighted average warrants Incremental Common Shares Attributable to Share Based Payment Arrangements Stock Option Add: Weighted average stock options Incremental common shares attributable to share based payment arrangements stock option. Add: Weighted average ESPP Incremental Common Shares Attributable to Equity Unit Purchase Agreements Incremental Common Shares Attributable to Share Based Payment Arrangements Rsu With Time Based Vesting Add: Weighted average RSUs with time-based vesting Incremental common shares attributable to share based payment arrangements Rsu with time based vesting. Schedule of Weighted Average Number of Shares [Table Text Block] Calculation of weighted average shares of common stock used in the computations of basic and diluted income (loss) per share amounts Deferred Offering Cost In Accrued Liability Deferred offering cost in accrued liability Deferred offering cost in accrued liability. Deferred Offering Cost In Accounts Payable Deferred offering cost in accounts payable Deferred offering cost in accounts payable. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate License Agreement Patent Right in Domestic Country Expiration Year Patent right covering LEVADEX expiry date License agreement patent right in domestic country expiration year. Stock Issued During Period, Shares, Issued for Cash Equity Offering sold and issued Equity Issuance, Per Share Amount Common stock offering price per share Stock Issued During Period, Value, Issued for Cash Issuance of common stock Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants remaining of exercised shares Stock Issued During Period, Shares, Conversion of Convertible Securities Stock issuance against the warrant